<DOC>
	<DOCNO>NCT03053128</DOCNO>
	<brief_summary>Coronary heart disease ( CHD ) public health care challenge . There three type treatment CHD , medication , percutaneous coronary intervention ( PCI ) coronary artery bypass graft ( CABG ) . However , end-stage CHD patient lose chance get treatment . Cardiac shock wave therapy ( CSWT ) new develop therapy patient , use ten country world . Safety , invasiveness , effectiveness advantage . Ischemia condition improve CSWT . There three city China run program CSWT , Kunming , Beijing Shanghai . The investigator design randomize double-blind study evaluate effectiveness safety CSWT .</brief_summary>
	<brief_title>Implication Cardiac Shock Wave Therapy Coronary Heart Disease</brief_title>
	<detailed_description>Coronary heart disease ( CHD ) public health care challenge , lead 3.5 million people die China every year . There three type treatment CHD , medication , percutaneous coronary intervention ( PCI ) coronary artery bypass graft ( CABG ) . However , end-stage CHD patient severe cardiac ischemia lose chance get treatment . Their quality life influence recurrent angina . Cardiac shock wave therapy ( CSWT ) new develop therapy patient , use ten country world . German Japan country earliest use CSWT . Safety , invasiveness , effectiveness advantage . Ischemia condition improve CSWT objective examination . New small vessel generation ischemia area find mice pig model . There three city China run program CSWT , Kunming , Beijing Shanghai . Beijing hospital CSWT machine Beijing . The investigator design randomize double-blind study evaluate effectiveness safety CSWT .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<criteria>1 . Multiple diffuse coronary artery stenosis coronary angiography candidate PCI CABG ; 2 . Myocardial ischemia and/or cardiac dysfunction objective exam ; 3 . Angina and/or heart failure could control optimal medication treatment coronary artery disease ; 4 . LVEF 30 % ; 5 . Signed informed consent 1 . Acute myocardial infarction ; 2 . Within one month PCI CABG ; 3 . Heart transplant patient ; 4 . Mechanic valve implantation patient ; 5 . Uncontrolled heart failure LVEF le 30 % ; 6 . Severe arrhythmia ; 7 . Pacemaker implantation patient ; 8 . Infective endocarditis ; 9 . Severe chronic obstructive pulmonary disease patient ; 10 . Pregnant nursing patient ; 11 . Silicone breast form patient ; 12 . Chest tumor patient ; 13 . Participant clinical trial time .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>cardiac ischemia</keyword>
</DOC>